Michael R. Lassen
Horsholm, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.
Journal: The New England journal of medicine
Published: December 24, 2010
Recent developments in the use of oral anticoagulants.
Journal: Expert opinion on pharmacotherapy
Published: June 25, 2009
AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery--TREK: a dose-ranging study.
Journal: Journal of thrombosis and haemostasis : JTH
Published: February 04, 2009
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
Journal: The New England journal of medicine
Published: June 27, 2008
SR123781A: a new once-daily synthetic oligosaccharide anticoagulant for thromboprophylaxis after total hip replacement surgery: the DRIVE (Dose Ranging Study in Elective Total Hip Replacement Surgery) study.
Journal: Journal of the American College of Cardiology
Published: January 18, 2008
Emergence of new oral antithrombotics: a critical appraisal of their clinical potential.
Journal: Vascular health and risk management
Published: January 01, 2008
The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement.
Journal: Journal of thrombosis and haemostasis : JTH
Published: September 18, 2007
Showing 1-8 of 8
Last Updated: 09/26/2026